Global Whole Genome and Exome Sequencing Markets, 2019-2023 - Diagnostic Factors / Interpreting the Code Otherwise / Changes in Agriculture/ Fertility Technology Comes of Age / Pathogen Challenges

News provided by

Jul 19, 2019, 07:45 ET

DUBLIN, July 19, 2019 /PRNewswire/ -- The "Whole Genome and Exome Sequencing Markets by Research, Clinical, Direct to Consumer, AgriBio & Tumor including Test Price and Volume Forecasts with Executive and Consultant Guides 2019 to 2023" report has been added to ResearchAndMarkets.com's offering.

Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?

A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well-funded players are racing for market share on a truly global stage. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

Our research makes you an expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data is provided without additional charges.

Key Topics Covered:

i. Whole Genome Sequencing Market - Strategic Situation Analysis

ii. Guide for Executives, Marketing, Sales and Business Development Staff

iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition
1.1 Whole Genome Sequencing Definition In This Report
1.1.1 Whole and Exome Sequencing
1.1.2 Research and Clinical
1.1.3 Direct to Consumer
1.1.4 AgriBio
1.1.5 Tumor Cells
1.2 The Genomics Revolution
1.3 Market Definition
1.3.1 Volumes
1.3.2 Prices
1.3.3 Revenue Market Size
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for laboratory testing
1.5 Sizing the Genome - Not What You Think
1.5.1 Cost, Price and Genome Size, Pricing Practice

2. Market Overview
2.1 Market Participants Play Different Roles
2.1.1 Instrument Manufacturer
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 DTC Lab
2.1.9 Sequencing Labs.
2.1.10 Audit body
2.2 Whole Genome Sequencing -Markets, Examples and Discussion
2.2.1 Direct to Consumer - Two Approaches
2.2.1.1 The New Age of Medical Information
2.2.1.2 Dangers in DTC-WGS - Health Costs and Regulation
2.2.1.3 Newborn and Prenatal - A Brave New World
2.2.1.4 DTC - How Many Segments?
2.2.2 Research Markets
2.2.2.1 Research Funding and Capital Expense
2.2.2.2 WGS Datasets Preferred
2.2.2.3 Existing research repurposed
2.2.2.4 Organism Wide Market
2.2.2.5 Service Suppliers Respond
2.2.3 Clinical - Understanding Germline and Somatic
2.2.3.1 Somatic - Chasing Mutations and Pharmacogenomics
2.2.4 Pathogen Testing
2.2.4.1 The Hepatitis C Story
2.2.4.2 Will the Microbiology Department Disappear?
2.2.5 AgriBio - Big Business
2.2.5.1 GMO is Here to Stay
2.2.5.2 WGS Benefits and Risks
2.2.5.3 The New Agriculture
2.3 Industry Structure
2.3.1 Hospital's Testing Share
2.3.2 Economies of Scale
2.3.3 Instrument Manufacturer Role
2.3.4 Healthcare Industry Impacts - Still Struggling
2.3.4.1 Can the Healthcare Industry Adapt?
2.3.4.2 Genetic Counselling as an Industry
2.3.4.3 WGES Adoption and Cannibalization
2.3.4.4 The Meaning of Grail
2.4 Profiles of Key Companies

10x Genomics, Inc
23andME Inc.
Agilent
Ancestry.com LLC
BGI Genomics Co. Ltd
Bio-Rad Laboratories, Inc.
Centogene
Color Genomics
Complete Genomics, Inc. - A BGI Company
Dante Labs
Datar Cancer Genetics Limited
Fabric Genomics
GE Global Research
Gencove
Gene by Gene, Ltd.
Genewiz
Genomic Health
Genomics England
Genomics Personalized Health (GPH)
Grail, Inc.
Helix
Human Longevity, Inc
Illumina
Invitae Corporation
Macrogen
Medgenome
MNG Labs
Nebula Genomics
Novogene Bioinformatics Technology Co., Ltd
Omega Bioservices
ORIG3N, Inc.
Oxford Nanopore Technologies
Pacific Biosciences
Perkin Elmer
Personalis
Qiagen Gmbh
Regeneron
Roche Molecular Diagnostics
Roswell Biotechnologies
Sequencing.com
Stratos Genomics
Sure Genomics, Inc.
Veritas Genetics

3. Market Trends
3.1 Factors Driving Growth
3.1.1 Diagnostic Factors
3.1.2 Interpreting the Code Otherwise.
3.1.3 Changes in Agriculture.
3.1.4 Fertility Technology Comes of Age
3.1.5 Pathogen Challenges
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers Price
3.2.2 Lower Costs

3.2.3 Healthcare Cost Concerns Curtail Growth.
3.2.4 Wellness has a downside
3.2.5 GMO Opposition Movement
3.3 Sequencing Instrumentation
3.3.1 Instrumentation Tenacity.
3.3.2 Declining Cost of Instruments Changes Industry Structure.
3.3.3 LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS.
3.3.4 Oxford Nanopore
3.3.4.1 What is Oxford Nanopore Sequencing?
3.3.4.2 What can Oxford Nanopore Sequencingt be used for?
3.3.4.3 Oxford Nanopore Products
3.3.5 Long Reads - Further Segmentation
3.3.6 Linked Reads
3.3.7 Targeted Sequencing Adopts CRISPR
3.3.8 New Sequencing Technologies

4. WGES Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section

Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing
Machine-learning system used to diagnose genetic diseases
Whole Genome Sequencing for healthy creates controversy
100,000 whole genomes sequenced in the NHS
Nebula Genomics Offers FREE Whole Genome Sequencing
Veritas Genetics has time limited WGS offer for $199
Veritas Genetics Launches Two New Whole Genome Sequencing Products
BGI unveils a powerful new sequencer
State of California Funds $2M Whole-Genome Sequencing Pilot
Rapid genome sequencing could revolutionize health care
Human Longevity Launches Whole Genome Product, MassMutual Partnerships
$1500 to sequence newborns in China
Newborns to Get Whole Genome Sequencing
Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
PerkinElmer Launches Clinical Whole Genome Sequencing Services
WGS and AI help clinicians scale precision oncology
Veritas Genetics Buys Curoverse
Dante Labs Partners With Amazon UK for Special 349 Whole Genome Sequencing
Toolbox Genomics Launches Personalized Wellness App in Sequencing.com's Revolutionary
App Market
CDC invests in WGS to help states respond to infectious disease threats
IBM Watson impresses in WGS brain tumour analysis
OneOme, Genome.One Partner to Offer Genetic Risk, PGx Service in Australia
WGS aids in Salmonella outbreak control
Nine Centres use Oxford Nanopore MinION to Sequence Human Genome
Esperite and BGI Genomics sign a strategic agreement to offer Whole Genome
Sequencing on a large scale
Easily Affordable Whole-genome Sequencing is Goal of Mayo Collaboration with Veritas
Regeneron Partners With AbbVie, Alnylam, AstraZeneca, Biogen, Pfizer to Sequence UK
Biobank Samples
MedGenome Expands Its NGS Capabilities and Forays Into Single-Cell Sequencing
Genomics England Adopts Edico's Dragen For NGS Analysis
BGI Says It Will Slash Cost of Gene Testing to $300
Position Statement Spells Out Fetal Diagnostic Sequencing Recommendations
Stratos Genomics Raises Funds to Ready for Commercialization
Whole genome sequencing identifies new genetic signature for autism
Inova, Veritas Genetics Partner to Offer Whole-Genome Sequencing, Interpretation
Dante Labs Announces 10,000 European Genome Project
PerkinElmer Extends Clinical Whole Genome Sequencing Services
Personalis Signs New Genome Sequencing Services Contract With VA
NorthShore Enlists Ambry Genetics for Whole-Exome Sequencing

For more information about this report visit https://www.researchandmarkets.com/r/8pnm6b

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets